Venetoclax plus gilteritinib is effective in preclinical models of <i>FLT3</i> -mutant BCL11B-a lineage-ambiguous leukemiaLindsey E. Montefiori, Charles G. Mullighan, Ilaria Iacobucci et al.|Blood|2025Cited by 7
Abstract 1197: B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinomaRebecca Epperly, Christopher DeRenzo, Emília M. Pinto et al.|Cancer Research|2023Cited by 5
EXTH-74. Nuclear Transport as a Therapeutic Vulnerability in ZFTA-RELA EpendymomaSiri Ippagunta, Kelsey C. Bertrand, Hua Sun et al.|Neuro-Oncology|2025Cited by 0